Skip to content
healthcare.dev

UBRELVY

NDC 85766-281, ubrogepant, tablet, from Sportpharm LLC.

Product NDC
85766-281
Status
Listed
Labeler
Sportpharm LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA211765
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/85766-281 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • UBROGEPANT100 mg/1

Pharmacologic classes

Calcitonin Gene-related Peptide Receptor Antagonist [EPC]; Calcitonin Gene-related Peptide Receptor Antagonists [MoA]

Package NDCNDC-11Package
85766-281-01857660281011 PACKET in 1 BOX (85766-281-01) / 1 TABLET in 1 PACKET
85766-281-108576602811010 PACKET in 1 BOX (85766-281-10) / 1 TABLET in 1 PACKET
85766-281-168576602811616 PACKET in 1 BOX (85766-281-16) / 1 TABLET in 1 PACKET
85766-281-308576602813030 PACKET in 1 BOX (85766-281-30) / 1 TABLET in 1 PACKET

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/36106b14-d410-4faf-a361-2871de8198c3

Use it

Look up 85766-281 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/85766-281 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 85766-281. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.